NICHOLAS BRACCIANO: Open Payments
NPI 1497140453 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 13 payments from 9 companies in 2025. Trend: 2023 $505 · 2024 $430 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Sage Therapeutics, LLC | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Indivior Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Orexo US, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: ARISTADA, COBENFY, ZURZUVAE, ABILIFY ASIMTUFII, INGREZZA, SUBLOCADE, Dyanavel XR, Zubsolv.
Industry payments across WI — which companies pay providers there.
